UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053690
Receipt number R000061269
Scientific Title A study for the effect of test food on biological response of infectious diseases in selected community. A randomized, double-blind, placebo-controlled, parallel-group comparison trial.
Date of disclosure of the study information 2024/03/01
Last modified on 2025/07/09 14:16:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study for the effect of test food on infectious diseases in selected community. A randomized, double-blind, placebo-controlled, parallel-group comparison trial.

Acronym

A study for the effect of test food on infectious diseases

Scientific Title

A study for the effect of test food on biological response of infectious diseases in selected community. A randomized, double-blind, placebo-controlled, parallel-group comparison trial.

Scientific Title:Acronym

A study for the effect of test food on infectious diseases

Region

Asia(except Japan)


Condition

Condition

None (Healthy adult)

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of test food on biological response of infectious diseases.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The effect of test food on biological response of infectious diseases on biological response of blood cells.

Key secondary outcomes

1. General wellbeing of participants evaluated by questionnaires.
2. Severity of infectious disease like illness
3. Expression of anti-infectious factors


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Daily one bottle of study product is administered to participant for consecutive 4 weeks.

Interventions/Control_2

Daily one bottle of placebo is administered to participant for consecutive 4 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

30 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Signed and dated informed consent form provided, after willingness of participants confirmed
2)Willingness to comply with all study procedures for the period of the study
3)Healthy adult (20 < Age < 30)
4)Persons who have COVID vaccine at least two times and more than 2 weeks have passed after last vaccination
5)Persons who are not currently infected with SARS-CoV2, and if they had been infected, at least 4 weeks have passed since recovery.
6)No underlying acute and/or chronic sickness from respiratory disease and/or gastrointestinal disease at enrolment.

Key exclusion criteria

1)Unable to provide signed and dated informed consent form
2)Unable to comply with all the study procedures
3)Allergic to milk and/or soy (contained within the study products)
4)Regularly using steroid drugs (immune suppressive drugs)
5)Any persons deemed inappropriate as participants by the principal investigators of this study
6)Those currently participating in other clinical trials (participants) or those who are planning to participate in other clinical trials during the study period
7)Women who are pregnant, or intend to get pregnant during the study period, or breastfeeding mothers
8)Cannot stop drinking alcohol for two days before sampling blood

Target sample size

110


Research contact person

Name of lead principal investigator

1st name Mai
Middle name
Last name Truong Tuyet

Organization

National Institute of Nutrition

Division name

National Institute of Nutrition

Zip code

100000

Address

48B Tang Bat Ho, Hanoi, Vietnam

TEL

+842439713137

Email

truongmai1976@gmail.com


Public contact

Name of contact person

1st name Hajjime
Middle name
Last name Nozawa

Organization

Kirin Holdings Co., Ltd.

Division name

Institute of health science

Zip code

251-8555

Address

Shonan iPark, 26-1,2- Muraoka-Higashi, Fujisawa, Kanagawa, Japan

TEL

+818022893085

Homepage URL


Email

h-nozawa@kirin.co.jp


Sponsor or person

Institute

National Institute of Nutrition

Institute

Department

Personal name



Funding Source

Organization

Kirin Holdings Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethical Committee of National Institute of Nutrition, Ministry of Health, Vietnam

Address

48B Tang Bat Ho, Hanoi, Vietnam

Tel

+84 24 3971 3137

Email

truongtuyetmai@dinhduong.org.vn


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Hai Phong Medical University


Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

110

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 11 Month 28 Day

Date of IRB

2023 Year 11 Month 28 Day

Anticipated trial start date

2023 Year 11 Month 29 Day

Last follow-up date

2024 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 02 Month 22 Day

Last modified on

2025 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061269